BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 17003096)

  • 21. Sleep-related breathing disorders in patients with Prader-Willi syndrome depending on the period of growth hormone treatment.
    Lecka-Ambroziak A; Jędrzejczak M; Wysocka-Mincewicz M; Szalecki M
    Endokrynol Pol; 2017; 68(6):676-681. PubMed ID: 29022650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; de Klerk LW; Festen DA; Duivenvoorden HJ; Otten BJ; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1274-80. PubMed ID: 19158197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal association between growth hormone therapy and obstructive sleep apnea in a child with Prader-Willi syndrome.
    Nixon GM; Rodda CP; Davey MJ
    J Clin Endocrinol Metab; 2011 Jan; 96(1):29-33. PubMed ID: 20943780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
    Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
    Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.
    Bakker NE; van Doorn J; Renes JS; Donker GH; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3041-9. PubMed ID: 26050733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.
    Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Troeman ZC; van Alfen-van der Velden AA; Otten BJ; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Oostdijk W; Bocca G; Mieke Houdijk EC; van Trotsenburg AS; Hoorweg-Nijman JJ; van Wieringen H; Vreuls RC; Jira PE; Schroor EJ; van Pinxteren-Nagler E; Willem Pilon J; Lunshof LB; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2307-14. PubMed ID: 22508707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep-disordered breathing in school-aged children with Prader-Willi syndrome.
    Schaefer J; Davey MJ; Nixon GM
    J Clin Sleep Med; 2022 Apr; 18(4):1055-1061. PubMed ID: 34870583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular and metabolic risk profile and acylation-stimulating protein levels in children with Prader-Willi syndrome and effects of growth hormone treatment.
    de Lind van Wijngaarden RF; Cianflone K; Gao Y; Leunissen RW; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1758-66. PubMed ID: 20173020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are sleep studies helpful in children with Prader-Willi syndrome prior to commencement of growth hormone therapy?
    Vandeleur M; Davey MJ; Nixon GM
    J Paediatr Child Health; 2013 Mar; 49(3):238-41. PubMed ID: 23438058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prader-Willi syndrome and sleep-disordered breathing.
    Miller J; Wagner M
    Pediatr Ann; 2013 Oct; 42(10):200-4. PubMed ID: 24126982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N
    Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
    Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
    J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleepiness and sleep disordered breathing in Prader-Willi syndrome: relationship to genotype, growth hormone therapy, and body composition.
    Williams K; Scheimann A; Sutton V; Hayslett E; Glaze DG
    J Clin Sleep Med; 2008 Apr; 4(2):111-8. PubMed ID: 18468308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children.
    Sohn YB; Kwak MJ; Kim SJ; Park SW; Kim CH; Kim MY; Kwon EK; Paik KH; Jin DK
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1371-7. PubMed ID: 20061428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M; Deal C; Van Vliet G
    J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep disordered breathing in infants with Prader-Willi syndrome during the first 6 weeks of growth hormone therapy: a pilot study.
    Miller JL; Shuster J; Theriaque D; Driscoll DJ; Wagner M
    J Clin Sleep Med; 2009 Oct; 5(5):448-53. PubMed ID: 19961030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of growth hormone therapy on cardiac dimensions in children and adolescents with Prader-Willi syndrome.
    Hauffa BP; Knaup K; Lehmann N; Neudorf U; Nagel B
    Horm Res Paediatr; 2011; 75(1):56-62. PubMed ID: 20924154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.